Beyond the ICD: Navigating Ventricular Tachycardia Suppression Strategies in the Modern Era

Area of Science:

• Cardiology
• Electrophysiology
• Medical Device Technology

Background:

• Management of ventricular tachycardia (VT) in patients with implantable cardioverter defibrillators (ICDs) presents a significant clinical challenge.
• VT suppression is often a necessary goal in these patients.
• Catheter ablation (CA) is increasingly utilized for VT management, with expanding indications and ongoing research into novel strategies for refractory cases.

Purpose of the Study:

• To synthesize current evidence regarding ventricular tachycardia (VT) suppression strategies.
• To review the various modalities employed for VT suppression in patients with ICDs.

Main Methods:

• Review of existing literature on VT management and suppression.
• Synthesis of data on catheter ablation (CA) and other interventional approaches.
• Analysis of outcomes related to VT recurrence and mortality.

Main Results:

• Patients with VT face increased risks of recurrent events and mortality, escalating with event frequency.
• Catheter ablation (CA) demonstrates superiority over antiarrhythmic drugs in reducing VT recurrence within the ischemic heart disease population.
• While acute freedom from VT is often achieved, long-term recurrence rates persist at high levels.
• Interventional approaches for VT suppression are expanding, showing improved acute success rates.
• Attaining long-term VT freedom is challenging, frequently necessitating the use of multiple suppression methods.

Conclusions:

• Catheter ablation (CA) is an effective strategy for acute VT suppression, particularly in ischemic heart disease.
• Long-term VT freedom remains a significant challenge, often requiring multimodal therapeutic approaches.
• Further research into novel procedural strategies is crucial for improving long-term outcomes in refractory VT cases.